Find and Pitch Jounalists, Get Your Story Covered

Tags: epistaxis pomalidomide bleeding disorder recurrent von willebrand disease

	Profile	Recent Articles on Subject
1	1387865 PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	NICE nod for Darzalex with lenalidomide and dexamethasone - about 1 year ago
2	Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA Healthcareoncologypharmacyeducation	Personalizing Treatments and Patient Education - 7 days ago Impact of SC Daratumumab - 21 days ago Evaluating New Data for Transplant-Eligible Patients With NDMM: PERSEUS, IsKia, and GMMG HD7 - 21 days ago Treatment Regimen Considerations - about 1 month ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Darzalex subcutaneous regimen approved by European Commission - 23 days ago
4	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Nipocalimab Shows Sustained Efficacy in Myasthenia Gravis - 29 days ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Real World CAR T-Cell Therapy Outcomes 'Favorable' in Relapsed/Refractory Myeloma - about 1 month ago Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 2 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 2 months ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 2 months ago Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies - 3 months ago Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC - 4 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 8 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 9 months ago All-Oral Therapy Promising in Higher-Risk MDS, CMML - 9 months ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - about 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - about 1 year ago
6	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 2 months ago Everything (Maybe) You Wanted to Know About Sarilumab for PMR - about 1 year ago
7	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 3 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 4 months ago Biosimilar Disease-Modifying Antirheumatic Drugs Show Potential Cost Savings for Rheumatoid Arthritis - 4 months ago Luspatercept Reduces Transfusion Burden Compared With Epoetin Alfa - 5 months ago FDA Approves Idecabtagene Vicleucel for Multiple Myeloma After 2 or More Lines of Therapy - 7 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 8 months ago Biosimilar Candidate GP40141 Found Similar to Romiplostim for Idiopathic Thrombocytopenic Purpura - 12 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 12 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - about 1 year ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - about 1 year ago
8	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 4 months ago Novel Combination Active in Large B-Cell Lymphoma, Even After CAR-T - 10 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - 11 months ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - 12 months ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - 12 months ago
9	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Durvalumab Plus Chemotherapy to Treat Endometrial Cancer - 5 months ago
10	Clare Wilson New Scientist Science news source. Worldwide sciencenewstechnology	Polycystic ovary syndrome could be treated with a malaria drug - 5 months ago

Journalists covering pomalidomide